Newsroom | 7268 results
Sorted by: Latest
-
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced business updates and financial results for the second quarter ended June 30, 2026. Recent Business Highlights Cash and cash equivalents totaled $101.6 million as of June 30, 2026. During Q2 the Company raised $46.8 million in net proceeds through an at-the-market (ATM) program, raising approxim...
-
Onto Innovation Reports 2026 Second Quarter Results
WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation reports record Q2 2026 revenue of $343M, strong AI-driven demand, and backlog surpassing $1 billion....
-
Emergence Appoints Ian Eslick as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--Emergence, a frontier agentic AI lab advancing safe autonomous AI, today announced the appointment of Ian Eslick as Chief Executive Officer. Eslick will lead the company's next phase of commercial growth, scaling enterprise adoption of Emergence's technology, expanding its go-to-market strategy, and driving operational execution as organizations increasingly deploy autonomous AI systems across mission-critical environments. As part of this evolution, Co-Founder Dr. Sa...
-
Fi and Verizon Partner to Integrate Connected Pet Care into the Modern Family Ecosystem
NEW YORK--(BUSINESS WIRE)--Fi, a leader in smart pet technology, and Verizon are bringing connected pet care directly into the modern family ecosystem. By integrating Fi’s state-of-the-art Fi Mini™ tracker directly into the newly redesigned Verizon Family app, the collaboration creates the industry’s first unified safety dashboard built for every member of the household—two-legged and four-legged alike. While traditional family plans treat pets as an afterthought, together Verizon and Fi are de...
-
CMS and MaxLinear Expand OpenZFS Storage for AI, Cloud, and Hyperscale Infrastructure
CARLSBAD, Calif.--(BUSINESS WIRE)--CMS adopts MaxLinear's Panther platform to accelerate OpenZFS storage for AI, cloud, hyperscale, and enterprise infrastructure....
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 44,434 restricted stock units (“RSUs”) will be granted to 24 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist’s Amended and Res...
-
Bruker Reports Second Quarter 2026 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026. Frank H. Laukien, Bruker’s President and CEO, commented: “We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieve...
-
Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic
NEW YORK--(BUSINESS WIRE)--Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a collaboration and co-exclusive licensing agreement with AstraZeneca. Under this agreement, the companies will advance AZD4241, a preclinical investigational therapy for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, with Pathos assuming responsibility for the early clinical devel...
-
Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended June 30, 2026. Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal third quarter 2026 earnings report and the investor presentation, or click https://investors.twist...
-
Dumpsters.com Built a Repeatable Sales Pipeline with ZoomInfo
VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that Dumpsters.com, a national dumpster rental company, built a repeatable sales pipeline and a large base of high-quality CRM contacts using ZoomInfo, according to the company. The company credits the shift with steady, sustained growth. Dumpsters.com sells into a broad, project-driven market, and its first problem was simply knowing who to call. The company needed to define its total addres...